Xcision Medical Systems, LLC is a medical technology company that has developed the GammaPod, an advanced stereotactic radiotherapy system with the potential to significantly improve the convenience and quality of life for patients with early-stage breast cancer. The company’s technology is designed to extend the benefits of radiation oncology to more patients and enable precision noninvasive treatments that allow patients to return to living fuller lives more quickly with less discomfort after receiving a cancer diagnosis. The system has been developed based on a patent licensed from the University of Maryland School of Medicine.
Xcision Medical Systems, LLC is a medical technology company that has developed the GammaPod, an advanced stereotactic radiotherapy system with the potential to significantly improve the convenience and quality of life for patients with early-stage breast cancer. The company’s technology is designed to extend the benefits of radiation oncology to more patients and enable precision noninvasive treatments that allow patients to return to living fuller lives more quickly with less discomfort after receiving a cancer diagnosis. The system has been developed based on a patent licensed from the University of Maryland School of Medicine.